Health Catalyst Inc. /zigman2/quotes/213268802/composite HCAT +0.03% increased the size of its planned initial public offering on Tuesday and raised the expected price range. The company said it is now planning to offer 7 million shares in the deal, up from a previous plan for 6 million, and raised the price range to $24 to $25 from a previous $20 to $23. "We are a leading provider of data and analytics technology and services to healthcare organizations," the company says in its prospectus. Goldman Sachs, JPMorgan and William Blair are lead underwriters on the deal with another four banks acting as co-managers. Proceeds of the deal will be used for working capital and other general corporate purposes, that may include acquisitions or other strategic deals.